Bladder Cancer
p21 Adenovirus Exhibits Growth Inhibitory Effect
Published in Cancer Weekly, April 4th, 2000
University of Texas researcher M.C. Hall and colleagues evaluated "whether p21 (WAF-1/CIP1) should be considered a potential candidate for human bladder cancer gene therapy. We determined: (1) the basal level of p21 expression in bladder cancer cell lines, (2) the response of bladder cancer cells to increased p21 expression following p21 adenovirus infection, and (3) the mechanism of growth inhibition produced by p21 overexpression."
Hall et al. published their study in Journal of...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
Source: Cancer Weekly (2000-04-04)
More Articles from Cancer Weekly
- Cancer Gene Therapy
Cytokine Gene Therapy Uses Fibroblasts to Enhance Tumor Immunity - Adoptive Immunotherapy
Gene Gun Generates Effector T Cells for Adoptive Therapy - Bladder Cancer
Monoclonal UBC-ELISA Test and NMP22 ELISA Test Compared - Cancer Gene Therapy
IFN Gene Transfer Up-Regulates p53 in Melanoma Cells - Cancer Therapies
Older Patients May Benefit From Aggressive Radiation Therapy - Cancer Vaccines
Genetic Vaccination with Self Protein Eradicates Melanoma in a Murine Model - More from this issue of Cancer Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
